Ishwaria Subbiah shared the following on LinkedIn:

”Such a pleasure to help kickoff the Texas Society of Clinical Oncology’s 2023 Annual Meeting. TxSCO President Sucharu Prakash, MD superbly moderated our discussion on “Navigating Health care Challenges in TX from Borderlands to Small Communities” with panelists Stephanie Broadnax Broussard, Neal Dave, all leaders in Texas Oncology, The US Oncology Network at the forefront of patient-centered care, Rosa White on cancer care at the border, and yours truly on broadening access to clinical trials, supportive care and clinician wellbeing.”
Grateful for such key practice-level partnerships with our Sarah Cannon Research Institute team to design and pilot innovative cancer clinical trials.
Thank you, Amanda, Morgan, and the entire Association of Community Cancer Centers (ACCC) team, for supporting Oncology State Societies at ACCC.”

Source: Ishwaria Subbiah/LinkedIn

Ishwaria Subbiah is the Executive Director for Cancer Care Equity and Professional Wellness at Sarah Cannon Research Institute (SCRI). In this role, Dr. Subbiah focuses on reducing cancer outcomes disparities and diversifying clinical trial participation within SCRI’s combined research network of over more than 1,300 physicians at over 250 locations in 24 states across the US. Dr. Subbiah is a globally recognized expert in geriatric oncology, symptom management, palliative care, and healthcare professional well-being. She previously was an associate professor in the Division of Cancer Medicine at the University of Texas MD Anderson Cancer Center. She is the Chair for the ASCO Women in Oncology working group and the ASCO State of Cancer Care in America initiative.